P
Peter D. Schellinger
Researcher at Ruhr University Bochum
Publications - 262
Citations - 18189
Peter D. Schellinger is an academic researcher from Ruhr University Bochum. The author has contributed to research in topics: Stroke & Thrombolysis. The author has an hindex of 64, co-authored 240 publications receiving 15911 citations. Previous affiliations of Peter D. Schellinger include University Hospitals of the Ruhr-University of Bochum & Heidelberg University.
Papers
More filters
Journal ArticleDOI
Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial
Hugues Chabriat,Claudio L. Bassetti,Ute Marx,Marie-Laure Audoli-Inthavong,Aurore Sors,Estelle Lambert,Marine Wattez,Dirk M. Hermann,Katharina Althaus,Sergi Amaro,Hee-Joon Bae,Zbigniew Bak,Leonardo Barbarini,Pietro Bassi,Rodrigo Bazan,Daniel Bereczki,Tomasz Berkowicz,Joerg Berrouschot,Dylan Blacquiere,Waldemar Brola,Kenneth Butcher,Pere Cardona,Jae-Kwan Cha,Geoffrey Cloud,David Cohen,Charlotte Cordonnier,Attila Csanyi,Anna Członkowska,Stephen N. Davis,Jesse Dawson,Nina De Klippel,Christian Denier,Philippe Desfontaines,Hans-Christoph Diener,Peter Dioszeghy,Diederik Willem Dippel,Laura Dorado,Andras Folyovich,Gabriel Rodriguez Freitas,Maurício André Gheller Friedrich,Waldemar Fryze,Rubens José Gagliardi,Marianna Gottschal,Rohan Grimley,Martin Grond,Klaus Gröschel,Hassan Hosseini,Yangha Hwang,Bernd Kallmuenzer,Usman A. Khan,Jong Sung Kim,Timothy Kleinig,Agnes Koves,Aida Lago Martin,Anetta Lasek-Bal,Giuseppe Lembo,Robin Lemmens,Ralf Lindert,Luiz Carlos Porcello Marrone,Maite Martinez Zabaleta,Jean-Louis Mas,Jaime Masjuan Vallejo,Mikael Mazighi,Cesar Minelli,Amit K Mistri,Carlos A. Molina,Francisco Moniche Alvarez,Carla H.C. Moro,Wim M. Mulleners,D. G. Nabavi,Jean-Philippe Neau,Bill O'brien,Csaba Ovary,Gyula Panczel,Man Seok Park,Thanh G. Phan,Suzanne Ragab,Konrad Rejdak,Gabriel R. de Freitas,Christine Roffe,Jaume Roquer Gonzalez,Luisa Rover,Gisele Sampaio Silva,Peter D. Schellinger,Tomas Segura Martin,Louise Shaw,Igor Sibon,Ondrej Skoda,Didier Smadja,Piotr Sobolewski,Hassan Soda,Nikola Sprigg,Maciej Swiat,Laszlo Szapary,Norbert Szegedi,Danilo Toni,Attila Valikovics,Geert Vanhooren,László Vécsei,Theodore Wein,Andrew Wong,Alvaro Ximenez Carrillo +101 more
TL;DR: The Randomized Efficacy and Safety Trial of Oral GABAA α5 receptor antagonist S44819 after Recent ischemic Event (RESTORE BRAIN) aimed to evaluate the safety and efficacy of S 44819 for enhancing clinical recovery of patients with ischaemic stroke.
Journal ArticleDOI
The evolving role of advanced MR imaging as a management tool for adult ischemic stroke: a Western-European perspective.
TL;DR: Although sufficiently large and methodologically sound studies with regard to cost effectiveness of MR imaging are lacking, the overall impression is that MR imaging has revolutionized not only the diagnosis but also the open and investigational management of neurologically ill patients.
Journal ArticleDOI
Embolic strokes of undetermined source: theoretical construct or useful clinical tool?:
Georgios Tsivgoulis,Aristeidis H. Katsanos,Martin Köhrmann,Valeria Caso,Robin Lemmens,Konstantinos Tsioufis,George P. Paraskevas,Natan M. Bornstein,Peter D. Schellinger,Andrei V. Alexandrov,Christos Krogias +10 more
TL;DR: Compared with the former diagnosis of CS, ESUS patients required thorough investigations; more comprehensive diagnostic work-up than is requested in current ESUS diagnostic criteria may assist clinicians in uncovering the source of brain embolism in CS patients and individualize treatment approaches.
Journal ArticleDOI
[Thrombolysis for ischemic stroke: an update].
TL;DR: Even though no randomized trials are available intraarterial thrombolysis is the treatment of choice for acute basilar occlusion, but if this intervention is not available an intravenous approach may be an equal alternative.
Journal ArticleDOI
Combining magnetic resonance imaging within six-hours of symptom onset with clinical follow-up at 24 h improves prediction of ‘malignant’ middle cerebral artery infarction
Anna Kruetzelmann,Frank Hartmann,Christoph Beck,Eric Juettler,Oliver C. Singer,Martin Köhrmann,Jan F. Kersten,Jan Sobesky,Christian Gerloff,Arno Villringer,Jens Fiehler,Tobias Neumann-Haefelin,Peter D. Schellinger,Joachim Röther,Götz Thomalla +14 more
TL;DR: Clinical follow-up examination after 24 h helps identify patients at risk of ‘malignant’ middle cerebral artery infarction that are missed by predictive algorithms based on early diffusion-weighted imaging lesion volume alone.